Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Horowitz

Showing results (681-690 of 701) with videos related to

Pageof 71
Sort By:
The Lancet. Oncology|June 28, 2021
Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort studyAntonio Braga, Gabriela Paiva, Ehsan Ghorani, et al.
International Journal of Cancer|November 13, 2019
Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancerAndrea P Myers, Panagiotis A Konstantinopoulos, William T Barry, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 24, 2022
Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-OophorectomyMeghna S Trivedi, Nadir Arber, Eitan Friedman, et al.
Gynecologic Oncology|March 9, 2025
Role of adjuvant radiotherapy modality on clinical outcomes for early-stage uterine carcinosarcomaKevin Tyan, Kevin X Liu, Alicia C Smart, et al.
Gynecologic Oncology|May 14, 2020
Gestational trophoblastic neoplasia lethality among Brazilian women: A retrospective national cohort studyFernanda Freitas, Antonio Braga, Mauricio Viggiano, et al.
Gynecologic Oncology|November 28, 2017
Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 StudyNeil S Horowitz, G Larry Maxwell, Austin Miller, et al.
Gynecologic Oncology|July 31, 2023
The impact of the distance traveled between residence and gestational trophoblastic neoplasia reference center and clinical outcomes in Brazilian womenAntonio Braga, Renata Lopes, Vanessa Campos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 20, 2016
Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomesC Y Cheah, D Chihara, S Horowitz, et al.
Cancers|June 2, 2021
Enhanced Efficacy of Aurora Kinase Inhibitors in G2/M Checkpoint Deficient <i>TP53</i> Mutant Uterine Carcinomas Is Linked to the Summation of LKB1-AKT-p53 InteractionsKatherine N Lynch, Joyce F Liu, Nikolas Kesten, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|October 9, 2022
Influence of COVID-19 pandemic on molar pregnancy and postmolar gestational trophoblastic neoplasia: An observational studyVanessa Campos, Gabriela Paiva, Lilian Padron, et al.
Pageof 71

Showing results (681-690 of 701) with videos related to

Sort By:
Pageof 71
The Lancet. Oncology|June 28, 2021
Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort studyAntonio Braga, Gabriela Paiva, Ehsan Ghorani, et al.
International Journal of Cancer|November 13, 2019
Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancerAndrea P Myers, Panagiotis A Konstantinopoulos, William T Barry, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 24, 2022
Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-OophorectomyMeghna S Trivedi, Nadir Arber, Eitan Friedman, et al.
Gynecologic Oncology|March 9, 2025
Role of adjuvant radiotherapy modality on clinical outcomes for early-stage uterine carcinosarcomaKevin Tyan, Kevin X Liu, Alicia C Smart, et al.
Gynecologic Oncology|May 14, 2020
Gestational trophoblastic neoplasia lethality among Brazilian women: A retrospective national cohort studyFernanda Freitas, Antonio Braga, Mauricio Viggiano, et al.
Gynecologic Oncology|November 28, 2017
Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 StudyNeil S Horowitz, G Larry Maxwell, Austin Miller, et al.
Gynecologic Oncology|July 31, 2023
The impact of the distance traveled between residence and gestational trophoblastic neoplasia reference center and clinical outcomes in Brazilian womenAntonio Braga, Renata Lopes, Vanessa Campos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 20, 2016
Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomesC Y Cheah, D Chihara, S Horowitz, et al.
Cancers|June 2, 2021
Enhanced Efficacy of Aurora Kinase Inhibitors in G2/M Checkpoint Deficient <i>TP53</i> Mutant Uterine Carcinomas Is Linked to the Summation of LKB1-AKT-p53 InteractionsKatherine N Lynch, Joyce F Liu, Nikolas Kesten, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|October 9, 2022
Influence of COVID-19 pandemic on molar pregnancy and postmolar gestational trophoblastic neoplasia: An observational studyVanessa Campos, Gabriela Paiva, Lilian Padron, et al.
Pageof 71